VISUAL ACUITY, ENDOTHELIAL CELL DENSITY AND POLYMEGATHISM AFTER IRIS-FIXATED LENS IMPLANTATION
Published 2022
- 26th ESCRS Winter Meeting
Reference: FP54
| Type: Abstracts
| DOI:
10.82333/ap64-3g72
Authors:
Nader Nassiri* 1
, Kourosh Sheibani 2
, Sara Kavousnezhad 3
1Ophthalmology,Imam Hossein Medical Center, Shahid Beheshti University of Medical Sciences, Tehran, Iran,Tehran,Iran, Islamic Republic Of, 2Ophthalmology,Basir Eye Health Research Center,Tehran,Iran, Islamic Republic Of, 3Ophthalmology,Vanak Eye Surgery Center, Tehran, Iran.,Tehran,Iran, Islamic Republic Of
Purpose
The purpose of this study was to evaluate the visual acuity as well as endothelial cell density (ECD) and polymegathism after iris-fixated lens (Artiflex® AC 401) implantation for correction of moderate to high myopia.
Setting
Vanak Ophthalmology Clinic, Tehran, Iran.
Methods
In this retrospective cross-sectional study, 55 eyes from 29 patients undergoing iris-fixated lens implantation for correction of myopia (−5.00 to −15.00 D) from 2007 to 2014 were evaluated. Uncorrected visual acuity, best spectacle-corrected visual acuity, refraction, ECD and polymegathism (coefficient of variation [CV] in the sizes of endothelial cells) were measured preoperatively and 6 months postoperatively.
Results
In the sixth month of follow-up, the uncorrected vision acuity was 20/25 or better in 81.5% of the eyes. The best-corrected visual acuity was 20/30 or better in 96.3% of the eyes, and more than 92% of the eyes had a refraction score of ±1 D from the target refraction. The mean corneal ECD of patients before surgery was 2,803±339 cells/mm2, which changed to 2,744±369 cells/mm2 six months after surgery (p=0.142). CV in the sizes of endothelial cells before the surgery was 25.7%±7.1% and six months after surgery it was 25.9%±5.4% (p=0.857).
Conclusion
Artiflex iris-fixated lens implantation is a suitable and predictable method for correction of moderate to high myopia. There was no statistically significant change in ECD and polymegathism (CV in the sizes of endothelial cells) after 6 months of follow-up.